Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: Q4QED9
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.533 |
CLV_NRD_NRD_1 | 133 | 135 | PF00675 | 0.538 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.685 |
CLV_PCSK_FUR_1 | 93 | 97 | PF00082 | 0.587 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.587 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.567 |
CLV_PCSK_KEX2_1 | 42 | 44 | PF00082 | 0.487 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.731 |
CLV_PCSK_PC1ET2_1 | 42 | 44 | PF00082 | 0.487 |
CLV_PCSK_PC1ET2_1 | 95 | 97 | PF00082 | 0.723 |
CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.465 |
DEG_APCC_DBOX_1 | 246 | 254 | PF00400 | 0.471 |
DEG_APCC_DBOX_1 | 61 | 69 | PF00400 | 0.428 |
DEG_SPOP_SBC_1 | 88 | 92 | PF00917 | 0.536 |
DOC_CYCLIN_yClb3_PxF_3 | 207 | 213 | PF00134 | 0.556 |
DOC_CYCLIN_yCln2_LP_2 | 199 | 205 | PF00134 | 0.455 |
DOC_MAPK_gen_1 | 42 | 50 | PF00069 | 0.398 |
DOC_MAPK_MEF2A_6 | 247 | 256 | PF00069 | 0.534 |
DOC_MAPK_MEF2A_6 | 287 | 296 | PF00069 | 0.446 |
DOC_MAPK_MEF2A_6 | 43 | 52 | PF00069 | 0.381 |
DOC_PP2B_LxvP_1 | 199 | 202 | PF13499 | 0.537 |
DOC_PP2B_LxvP_1 | 203 | 206 | PF13499 | 0.477 |
DOC_PP4_FxxP_1 | 188 | 191 | PF00568 | 0.636 |
DOC_PP4_FxxP_1 | 256 | 259 | PF00568 | 0.534 |
DOC_USP7_MATH_1 | 31 | 35 | PF00917 | 0.420 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.581 |
DOC_USP7_UBL2_3 | 38 | 42 | PF12436 | 0.481 |
DOC_WW_Pin1_4 | 78 | 83 | PF00397 | 0.613 |
LIG_14-3-3_CanoR_1 | 12 | 19 | PF00244 | 0.476 |
LIG_BIR_III_2 | 66 | 70 | PF00653 | 0.464 |
LIG_EVH1_1 | 203 | 207 | PF00568 | 0.439 |
LIG_FHA_1 | 283 | 289 | PF00498 | 0.470 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.412 |
LIG_FHA_2 | 102 | 108 | PF00498 | 0.493 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.512 |
LIG_FHA_2 | 49 | 55 | PF00498 | 0.505 |
LIG_LIR_Gen_1 | 114 | 121 | PF02991 | 0.640 |
LIG_LIR_Gen_1 | 13 | 23 | PF02991 | 0.411 |
LIG_LIR_Gen_1 | 234 | 243 | PF02991 | 0.522 |
LIG_LIR_Gen_1 | 46 | 57 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 114 | 118 | PF02991 | 0.643 |
LIG_LIR_Nem_3 | 13 | 19 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 234 | 239 | PF02991 | 0.469 |
LIG_LIR_Nem_3 | 25 | 29 | PF02991 | 0.381 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.384 |
LIG_MYND_1 | 201 | 205 | PF01753 | 0.670 |
LIG_MYND_1 | 208 | 212 | PF01753 | 0.609 |
LIG_PTB_Apo_2 | 219 | 226 | PF02174 | 0.453 |
LIG_SH2_STAT3 | 121 | 124 | PF00017 | 0.559 |
LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.511 |
LIG_SH3_2 | 204 | 209 | PF14604 | 0.530 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.650 |
LIG_SH3_3 | 205 | 211 | PF00018 | 0.478 |
LIG_SH3_CIN85_PxpxPR_1 | 204 | 209 | PF14604 | 0.530 |
LIG_SUMO_SIM_anti_2 | 249 | 254 | PF11976 | 0.534 |
LIG_SUMO_SIM_par_1 | 276 | 283 | PF11976 | 0.515 |
LIG_TRAF2_1 | 82 | 85 | PF00917 | 0.722 |
LIG_WRC_WIRS_1 | 32 | 37 | PF05994 | 0.544 |
LIG_WRC_WIRS_1 | 49 | 54 | PF05994 | 0.500 |
LIG_WW_2 | 201 | 204 | PF00397 | 0.446 |
LIG_WW_3 | 206 | 210 | PF00397 | 0.550 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.528 |
MOD_CK1_1 | 282 | 288 | PF00069 | 0.410 |
MOD_CK1_1 | 91 | 97 | PF00069 | 0.635 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.502 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.548 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.544 |
MOD_GlcNHglycan | 236 | 239 | PF01048 | 0.334 |
MOD_GlcNHglycan | 282 | 285 | PF01048 | 0.386 |
MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.737 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.475 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.487 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.514 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.700 |
MOD_LATS_1 | 130 | 136 | PF00433 | 0.511 |
MOD_N-GLC_1 | 161 | 166 | PF02516 | 0.725 |
MOD_N-GLC_1 | 269 | 274 | PF02516 | 0.291 |
MOD_NEK2_1 | 225 | 230 | PF00069 | 0.534 |
MOD_NEK2_1 | 269 | 274 | PF00069 | 0.491 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.507 |
MOD_NEK2_2 | 31 | 36 | PF00069 | 0.426 |
MOD_PKA_1 | 132 | 138 | PF00069 | 0.672 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.476 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.749 |
MOD_Plk_1 | 19 | 25 | PF00069 | 0.458 |
MOD_Plk_1 | 43 | 49 | PF00069 | 0.458 |
MOD_Plk_4 | 44 | 50 | PF00069 | 0.410 |
MOD_ProDKin_1 | 78 | 84 | PF00069 | 0.617 |
MOD_SUMO_rev_2 | 106 | 111 | PF00179 | 0.696 |
TRG_ER_diArg_1 | 132 | 134 | PF00400 | 0.574 |
TRG_ER_diArg_1 | 148 | 151 | PF00400 | 0.641 |
TRG_ER_diArg_1 | 174 | 177 | PF00400 | 0.720 |
TRG_NLS_MonoExtN_4 | 93 | 99 | PF00514 | 0.701 |
TRG_Pf-PMV_PEXEL_1 | 230 | 234 | PF00026 | 0.258 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZY5 | Leptomonas seymouri | 52% | 100% |
A0A1X0P0T6 | Trypanosomatidae | 36% | 100% |
A0A3Q8IAN2 | Leishmania donovani | 92% | 99% |
A0A3R7MFN4 | Trypanosoma rangeli | 35% | 100% |
A4H8Z8 | Leishmania braziliensis | 77% | 98% |
A4HXC9 | Leishmania infantum | 94% | 100% |
D0A4S0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 100% |
E9AR24 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 98% |
V5AZY6 | Trypanosoma cruzi | 37% | 100% |